Ubiquitin Ligase Cbl-b Is Involved in Icotinib (BPI-2009H)-Induced Apoptosis and G1 Phase Arrest of EGFR Mutation-Positive Non-Small-Cell Lung Cancer

Epidermal growth factor receptor (EGFR) is one of the most promising targets for non-small-cell lung cancer (NSCLC). Icotinib, a highly selective EGFR tyrosine kinase inhibitor (EGFR-TKI), has shown promising clinical efficacy and safety in patients with NSCLC. The exact molecular mechanism of icoti...

Descripción completa

Detalles Bibliográficos
Autores principales: Mu, Xiaodong, Zhang, Ye, Qu, Xiujuan, Hou, Kezuo, Kang, Jian, Hu, Xuejun, Liu, Yunpeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615596/
https://www.ncbi.nlm.nih.gov/pubmed/23586056
http://dx.doi.org/10.1155/2013/726375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615596/
https://www.ncbi.nlm.nih.gov/pubmed/23586056
http://dx.doi.org/10.1155/2013/726375

Ejemplares similares